Biller Jonathan sold VRTX
February 11, 2026 · Form 4 insider transaction
Biller Jonathan sold 1,925 shares of Vertex Pharmaceuticals Incorporated at $460.43 per share, a transaction worth $886.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,925
Price
$460.43
Total value
$886.3K
InsiderBiller Jonathan
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 11, 2026
Filing dateFebruary 12, 2026
Shares owned after20,819
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025.